|Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4|
M Todaro, MP Alea, AB Di Stefano, P Cammareri, L Vermeulen, F Iovino, ...
Cell stem cell 1 (4), 389-402, 2007
|Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study|
HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ...
British journal of cancer 85 (5), 692-696, 2001
|STAT proteins: from normal control of cellular events to tumorigenesis|
V Calò, M Migliavacca, V Bazan, M Macaluso, M Buscemi, N Gebbia, ...
Journal of cellular physiology 197 (2), 157-168, 2003
|Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development|
M Gironella, M Seux, MJ Xie, C Cano, R Tomasini, J Gommeaux, S Garcia, ...
Proceedings of the National Academy of Sciences 104 (41), 16170-16175, 2007
|The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of …|
A Russo, V Bazan, B Iacopetta, D Kerr, T Soussi, N Gebbia
Journal of clinical oncology 23 (30), 7518-7528, 2005
|HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007)|
N Termine, V Panzarella, S Falaschini, A Russo, D Matranga, L Lo Muzio, ...
Annals of Oncology 19 (10), 1681-1690, 2008
|Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli|
C Garofalo, M Koda, S Cascio, M Sulkowska, L Kanczuga-Koda, ...
Clinical Cancer Research 12 (5), 1447-1453, 2006
|Founder mutations in BRCA1 and BRCA2 genes|
R Ferla, V Calo, S Cascio, G Rinaldi, G Badalamenti, I Carreca, ...
Annals of Oncology 18, vi93-vi98, 2007
|Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype|
V Bazan, M Migliavacca, I Zanna, C Tubiolo, N Grassi, MA Latteri, ...
Annals of Oncology 13 (9), 1438-1446, 2002
|High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice|
D Santini, F Loupakis, B Vincenzi, I Floriani, I Stasi, E Canestrari, E Rulli, ...
Oncologist 13 (12), 1270, 2008
|miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells|
S Cascio, A D'Andrea, R Ferla, E Surmacz, E Gulotta, V Amodeo, V Bazan, ...
Journal of cellular physiology 224 (1), 242-249, 2010
|Ras family genes: an interesting link between cell cycle and cancer|
M Macaluso, G Russo, C Cinti, V Bazan, N Gebbia, A Russo
Journal of cellular physiology 192 (2), 125-130, 2002
|Male breast cancer|
L Ottini, D Palli, S Rizzo, M Federico, V Bazan, A Russo
Critical reviews in oncology/hematology 73 (2), 141-155, 2010
|Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib|
B Vincenzi, D Santini, A Russo, R Addeo, F Giuliani, L Montella, S Rizzo, ...
The oncologist 15 (1), 85, 2010
|Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients|
D Santini, G Schiavon, B Vincenzi, L Gaeta, F Pantano, A Russo, ...
PloS one 6 (4), e19234, 2011
|Liquid biopsies in lung cancer: the new ambrosia of researchers|
C Rolfo, M Castiglia, D Hong, R Alessandro, I Mertens, G Baggerman, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 539-546, 2014
|Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia …|
V Bazan, V Agnese, S Corsale, V Calo, MR Valerio, MA Latteri, S Vieni, ...
Annals of oncology 16, iv50-iv55, 2005
|Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?|
D Santini, B Vincenzi, R Addeo, C Garufi, G Masi, M Scartozzi, A Mancuso, ...
Annals of Oncology 23 (9), 2313-2318, 2012
|Hereditary ovarian cancer|
A Russo, V Calò, L Bruno, S Rizzo, V Bazan, G Di Fede
Critical reviews in oncology/hematology 69 (1), 28-44, 2009
|Patterns of genomic instability in gastric cancer: clinical implications and perspectives|
L Ottini, M Falchetti, R Lupi, P Rizzolo, V Agnese, G Colucci, V Bazan, ...
Annals of Oncology 17, vii97-vii102, 2006